ST-899
ST-899 is a novel platelet-activating factor (PAF) receptor antagonist. ST-899 can significantly reduce the mortality of mice with endotoxin (LPS) -induced shock. ST-899 can significantly inhibit the increase in serum tumor necrosis factor (TNF) levels induced by LPS, but has no effect on interleukin-6 (IL-6) . The regulatory mechanism of ST-899 is to block the positive feedback loop between PAF and TNF, thereby reducing the inflammatory response. ST-899 can be used to study inflammatory diseases such as septic shock[1].
Product Specifications
CAS Number
143484-41-7
UNSPSC
12352005
Target
Platelet-activating Factor Receptor (PAFR) ; TNF Receptor
Related Pathways
Apoptosis; GPCR/G Protein
Field of Research
Inflammation/Immunology
Smiles
O=C(O/1)C2=CC=C(Cl)C=C2C1=C\COC(C[C@@H](OC(CC(C)C)=O)C[N+](C)(C)C)=O.[Br-]
Molecular Formula
C22H29BrClNO6
Molecular Weight
518.83
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bottle, Advanced TC, 250ml, 75cm2, polystyrene, blue screw cap with filter, subpacked per 5 pieces, STERILE, 120 pieces per CAR
Lentiviral human CRY2 sgRNA gene knockout kit - Lentiviral human CRY2 sgRNA gene knockout kit (25)